NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vicore Pharma Holding AB (publ) (ST: VICO)

 
VICO Technical Analysis
5
As on 9th May 2025 VICO STOCK Price closed @ 7.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.55 & Strong Sell for SHORT-TERM with Stoploss of 14.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VICOSTOCK Price

Open 7.65 Change Price %
High 8.01 1 Day 0.32 4.20
Low 7.62 1 Week -0.35 -4.22
Close 7.94 1 Month 0.49 6.58
Volume 246597 1 Year -7.62 -48.97
52 Week High 23.30 | 52 Week Low 6.32
 
ST Sweden Most Active Stocks
FING-B 0.02 0.00%
HDW-B 0.00 %
ENERS 0.00 %
WYLD 0.04 0.00%
S2M 0.01 0.00%
QUIA 0.01 0.00%
SBB-B 3.85 -3.99%
IMMNOV 0.40 17.65%
LUNE 21.97 6.65%
QLINEA 0.04 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
SPIFF 0.04 33.33%
RAY-B 314.50 30.77%
RAY-B 314.50 30.77%
LIDDS 0.05 25.00%
SCOUT 0.22 22.22%
IMMNOV 0.40 17.65%
CHECK 9.40 17.50%
COINETHE 177.19 16.67%
ELIC 5.12 16.36%
 
ST Sweden Top Losers Stocks
BUFAB 81.74 -79.96%
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
 
 
VICO
Daily Charts
VICO
Intraday Charts
Whats New @
Bazaartrend
VICO
Free Analysis
 
VICO Important Levels Intraday
RESISTANCE8.69
RESISTANCE8.45
RESISTANCE8.30
RESISTANCE8.15
SUPPORT7.73
SUPPORT7.58
SUPPORT7.43
SUPPORT7.19
 
VICO Forecast May 2025
4th UP Forecast12.37
3rd UP Forecast10.95
2nd UP Forecast10.07
1st UP Forecast9.19
1st DOWN Forecast6.69
2nd DOWN Forecast5.81
3rd DOWN Forecast4.93
4th DOWN Forecast3.51
 
VICO Weekly Forecast
4th UP Forecast10.37
3rd UP Forecast9.59
2nd UP Forecast9.11
1st UP Forecast8.63
1st DOWN Forecast7.25
2nd DOWN Forecast6.77
3rd DOWN Forecast6.29
4th DOWN Forecast5.51
 
VICO Forecast2025
4th UP Forecast42.65
3rd UP Forecast31.52
2nd UP Forecast24.64
1st UP Forecast17.76
1st DOWN Forecast-1.88
2nd DOWN Forecast-8.76
3rd DOWN Forecast-15.64
4th DOWN Forecast-26.77
 
 
VICO Other Details
Segment EQ
Market Capital 1262981376.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VICO Address
VICO
 
VICO Latest News
 
Your Comments and Response on Vicore Pharma Holding AB (publ)
 
VICO Business Profile
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), diffuse systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden. Address: Kronhusgatan 11, Gothenburg, Sweden, 411 05
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service